Skip to main content
Clinical Trials/NCT05865626
NCT05865626
Completed
N/A

A Pilot Study to Evaluate Video Observed Treatment Among Tuberculosis Patients From Lambaréné Using an Instant Messenger Application

Centre de Recherche Médicale de Lambaréné1 site in 1 country30 target enrollmentOctober 10, 2018
ConditionsTuberculosis

Overview

Phase
N/A
Intervention
Not specified
Conditions
Tuberculosis
Sponsor
Centre de Recherche Médicale de Lambaréné
Enrollment
30
Locations
1
Primary Endpoint
feasibility assessment
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

This pilot study aimed to assess the feasibility of using an instant messenger to monitor drug intake in tuberculosis patients and to assess cash incentive to improve adherence to drug intake

Detailed Description

At the initial visit, the inclusion criteria are cross-checked, the subject is informed of the study procedures, and an informed consent form is signed by subjects willing to participate. For the participants from the intervention group, the research team will provide a smartphone with the WhatsApp application to each participant. At the initial visit, the research team will explain to the participants how to use the phone and the instant messenger application for the study. Briefly, the subject is filmed while taking the drug. This can be via a "selfie" or by a family member. The video is then sent to the study phone contact. Once the video is received by an investigator, a message will be sent back to the participant's mobile phone acknowledging receipt of the video. An investigator trained on the DOT protocol, will review the video clips to assess if the drug was taken correctly or not. A daily log is filled in to keep track of drug intake for each participant. Participants from both the control and intervention group are seen once per month in person for follow-ups and getting new drugs. At these time points information on drug intake is gathered.

Registry
clinicaltrials.gov
Start Date
October 10, 2018
End Date
June 30, 2022
Last Updated
2 years ago
Study Type
Interventional
Study Design
Crossover
Sex
All

Investigators

Sponsor
Centre de Recherche Médicale de Lambaréné
Responsible Party
Principal Investigator
Principal Investigator

EDOA Jean Ronald

Dr

Centre de Recherche Médicale de Lambaréné

Eligibility Criteria

Inclusion Criteria

  • Older than 18 years
  • Signed informed consent form
  • Living in an area with mobile phone coverage
  • Have at least 3 months of treatment remaining

Exclusion Criteria

  • Not being able to use a smartphone and unlikely to learn how to

Outcomes

Primary Outcomes

feasibility assessment

Time Frame: at the end of study (2 years)

proportion of participants in the intervention groups who regularly send the videos throughout the follow-up.

Secondary Outcomes

  • adherence to the VOT(at the end of study (2 years))
  • effect of cash incentives on adherence to the VOT(at the end of study (2 years))

Study Sites (1)

Loading locations...

Similar Trials